First United Bank & Trust lowered its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 0.7% in the 4th quarter, Holdings Channel.com reports. The firm owned 14,760 shares of the company’s stock after selling 97 shares during the quarter. First United Bank & Trust’s holdings in Procter & Gamble were worth $2,475,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently made changes to their positions in the company. International Assets Investment Management LLC increased its holdings in Procter & Gamble by 19,030.8% in the 3rd quarter. International Assets Investment Management LLC now owns 3,693,593 shares of the company’s stock worth $639,730,000 after acquiring an additional 3,674,286 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Procter & Gamble by 7.0% in the third quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company’s stock worth $9,538,327,000 after purchasing an additional 3,619,466 shares during the period. Franklin Resources Inc. increased its stake in shares of Procter & Gamble by 10.2% in the third quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company’s stock worth $3,290,573,000 after purchasing an additional 1,760,214 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of Procter & Gamble during the 3rd quarter valued at $301,950,000. Finally, AMF Tjanstepension AB lifted its stake in shares of Procter & Gamble by 416.1% during the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock valued at $315,016,000 after buying an additional 1,466,115 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
Insider Activity
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the sale, the insider now directly owns 11,595 shares of the company’s stock, valued at $2,002,804.35. The trade was a 52.47 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.18% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings data on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.88 billion during the quarter, compared to the consensus estimate of $21,657,595.49 billion. During the same quarter last year, the firm earned $1.84 earnings per share. The firm’s quarterly revenue was up 2.1% compared to the same quarter last year. As a group, equities research analysts forecast that The Procter & Gamble Company will post 6.92 EPS for the current year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be given a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, January 24th. This represents a $4.03 annualized dividend and a dividend yield of 2.45%. Procter & Gamble’s dividend payout ratio (DPR) is 69.48%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on the company. Evercore ISI increased their price target on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Stifel Nicolaus decreased their target price on Procter & Gamble from $167.00 to $161.00 and set a “hold” rating on the stock in a research note on Friday, January 17th. UBS Group dropped their price target on Procter & Gamble from $196.00 to $189.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. DA Davidson reiterated a “buy” rating and set a $209.00 price objective on shares of Procter & Gamble in a research report on Friday, December 27th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating for the company in a research report on Thursday, January 16th. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $179.65.
View Our Latest Research Report on PG
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- What is the Dogs of the Dow Strategy? Overview and Examples
- Oracle Announces Game-Changing News for the AI Industry
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- How to Use Stock Screeners to Find Stocks
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.